The FDA has granted emergency use authorization to the Rutgers RUCDR Infinite Biologics initiative and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavirus. #RutgersImpact t.co/n3U8UUSBAM